Bradley L

No ORCID on file · 4 papers in corpus · active 2013-2022
2022
A Call-to-Action for Clinicians to Implement Evidence-Based Best Practices When Caring for Women with Uterine Fibroids.
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-022-00877-3

Uterine fibroids are common benign tumors that occur in up to 80% of women. Approximately half of the women affected experience considerable physical, psychological, and economic burdens and impact on quality of life due to symptoms such as…

2018
Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
Obstetrics and gynecology ·doi:10.1097/aog.0000000000002933

ObjectiveTo evaluate elagolix, an oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy, in premenopausal women with heavy menstrual bleeding (greater than 80 mL per month) associated with uterine leiomyoma…

2016
An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2015.12.012
2013
The impact of uterine leiomyomas: a national survey of affected women.
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2013.07.017

ObjectiveWe sought to characterize the impact of uterine leiomyomas (fibroids) in a racially diverse sample of women in the United States.Study designA total of 968 women (573 white, 268 African American, 127 other races) aged 29-59 years w…